Stocks News

LAST PRICE
174.0000
TODAY'S CHANGE (%)
Trending Down-7.1800 (-3.9629%)

Bid / Lots
174.5000/ 8
Ask / Lots
175.0000/ 1
Open / Previous Close
178.1100 / 181.1800
Day Range
Low 174.0000
High 179.4751
52 Week Range
Low 173.8750
High 268.2950
Volume
1,755,618
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: LLY, RHHBY, BIIB
  
  By Bill Alpert
  
  Roche Holding has one of the most promising treatments for Alzheimer's in clinical trials. The drug is several years away from reaching the market, however.
- DJ Biogen Is Maintained at Outperform by Oppenheimer, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 14:19 ET (18:19 GMT)
- DJ Biogen Is Maintained at Equal-Weight by Barclays, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 14:11 ET (18:11 GMT)
- DJ Biogen Is Maintained at Buy by TD Cowen, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 13:07 ET (17:07 GMT)
- RBC Adjusts Biogen's Price Target to $260 From $269, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: BIIB
  11:13 AM EDT, 10/31/2024 (MT Newswires) -- Biogen (BIIB) has an average rating of outperform and price targets ranging from $180 to $342, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from m...

Yesterday
- BioNTech to Host Innovation Series R&D Day on November 14, 2024, from 16 hours ago by Dow Jones
  16 hours ago by Dow Jones
  Companies Mentioned: BNTX
- Moderna to Present at Upcoming Conferences in November 2024, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: MRNA
Oct 30, 2024
- European Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday Trading, from 11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires
  11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: GSK, PHG, VEON, GRFS, VRNA, AUTL, OPRA, GNFT, BCYC, AZN, BCS, CRTO, TCBP, MTLS, CRH, CLLS
Oct 29, 2024
- Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise, from 9:35AM ET on Tuesday Oct 29, 2024 by MT Newswires
  9:35AM ET on Tuesday Oct 29, 2024 by MT Newswires
  Companies Mentioned: JNJ, GRFS
- Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: GRFS
Oct 28, 2024
- DJ Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com, from 9:48AM ET on Monday Oct 28, 2024 by Dow Jones
  9:48AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: GSK, PFE, MRNA
- DJ Icon Is Maintained at Buy by Truist Securities, from 9:30AM ET on Monday Oct 28, 2024 by Dow Jones
  9:30AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: ICLR
- DJ Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com, from 7:53AM ET on Monday Oct 28, 2024 by Dow Jones
  7:53AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: MRNA
- Merck, Moderna Begin Phase 3 Trial of V940, Keytruda Combination, from 7:34AM ET on Monday Oct 28, 2024 by MT Newswires
  7:34AM ET on Monday Oct 28, 2024 by MT Newswires
  Companies Mentioned: MRK, MRNA
- Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA(R) (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC), from 6:45AM ET on Monday Oct 28, 2024 by Dow Jones
  6:45AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: MRK, MRNA

Biogen Inc
NASDAQ:BIIBUnited States

Search Criteria

Yesterday

DJ Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com, from 7 hours ago by Dow Jones

DJ Biogen Is Maintained at Outperform by Oppenheimer, from 10 hours ago by Dow Jones

DJ Biogen Is Maintained at Equal-Weight by Barclays, from 10 hours ago by Dow Jones

DJ Biogen Is Maintained at Buy by TD Cowen, from 11 hours ago by Dow Jones

RBC Adjusts Biogen's Price Target to $260 From $269, from 13 hours ago by MT Newswires

Peers Headlines

Yesterday

BioNTech to Host Innovation Series R&D Day on November 14, 2024, from 16 hours ago by Dow Jones

Moderna to Present at Upcoming Conferences in November 2024, from 17 hours ago by Dow Jones

Oct 30, 2024

European Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday Trading, from 11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires

Oct 29, 2024

Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise, from 9:35AM ET on Tuesday Oct 29, 2024 by MT Newswires

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution, from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 28, 2024

DJ Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com, from 9:48AM ET on Monday Oct 28, 2024 by Dow Jones

DJ Icon Is Maintained at Buy by Truist Securities, from 9:30AM ET on Monday Oct 28, 2024 by Dow Jones

DJ Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com, from 7:53AM ET on Monday Oct 28, 2024 by Dow Jones

Merck, Moderna Begin Phase 3 Trial of V940, Keytruda Combination, from 7:34AM ET on Monday Oct 28, 2024 by MT Newswires

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA(R) (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC), from 6:45AM ET on Monday Oct 28, 2024 by Dow Jones